A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia

Clinical trial NCT06401603 · RECRUITING

Trial details

NCT number: NCT06401603
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Chronic Myeloid Leukemia Philadelphia Chromosome-Positive Acute Myeloid Leukemia

Start date: 2024-08-06
Primary completion: 2027-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.